SION Sionna Therapeutics, Inc.
Fundamentals / CIK 0002036042 / USDSionna Therapeutics, Inc. reported $263.3M in total assets and a net loss of $109.5M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SION in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$120.5M Operating profit
-
Net Income FY 2025-$109.5M GAAP bottom line
-
Diluted EPS FY 2025-$2.42 Split-adjusted
-
Free Cash Flow FY 2025-$79.61M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$83.88M Total debt: $7.75M
Annual revenue and net income
2 fiscal years (2024 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 |
|---|---|---|
| Research & Development | $60.26M | $57.29M |
| Total Operating Expenses | $88.98M | $70.56M |
| Operating Income | -$88.98M | -$70.56M |
| EBITDA | -$88.33M | -$69.89M |
| Interest Income | $13.29M | $8.17M |
| Income Tax Expense | $0 | $0 |
| Net Income | -$75.27M | -$61.69M |
| Basic EPS | -$1.88 | -$15.99 |
| Diluted EPS | -$1.88 | -$15.99 |
| Basic Shares Outstanding | 40.0M | 3.9M |
| Diluted Shares Outstanding | 40.0M | 3.9M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $22.02M | $21.86M | $18.96M | $15.17M | $16.04M | $15.38M | $13.67M | $14.25M |
| Total Operating Expenses | $34.82M | $32.47M | $29.60M | $23.61M | $23.80M | $21.91M | $19.66M | $18.13M |
| Operating Income | -$34.82M | -$32.47M | -$29.60M | -$23.61M | -$23.80M | -$21.91M | -$19.66M | -$18.13M |
| EBITDA | -$34.62M | -$32.27M | -$29.45M | -$23.46M | -$23.70M | -$21.81M | -$19.50M | -$17.97M |
| Interest Income | $2.41M | $2.59M | $2.82M | $3.17M | $3.46M | $3.67M | $3.00M | $2.12M |
| Net Income | -$32.42M | -$29.89M | -$26.78M | -$20.44M | -$20.28M | -$18.07M | -$16.48M | -$15.85M |
| Basic EPS | -$0.72 | -$0.66 | -$0.60 | -- | -$0.46 | -$0.41 | -$0.62 | -- |
| Diluted EPS | -$0.72 | -$0.66 | -$0.60 | -- | -$0.46 | -$0.41 | -$0.62 | -- |
| Basic Shares Outstanding | 45.2M | 45.1M | 44.9M | -- | 44.3M | 44.1M | 26.6M | -- |
| Diluted Shares Outstanding | 45.2M | 45.1M | 44.9M | -- | 44.3M | 44.1M | 26.6M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 |
|---|---|---|
| Cash & Cash Equivalents | $58.45M | $37.79M |
| Cash & Short-Term Investments | $58.45M | $37.79M |
| Total Current Assets | $241.4M | $151.0M |
| Property, Plant & Equipment, Net | $2.23M | $2.47M |
| Other Non-Current Assets | $0 | $2.99M |
| Total Non-Current Assets | $84.53M | $34.76M |
| Total Assets | $326.0M | $185.8M |
| Accounts Payable | $769K | $1.19M |
| Other Current Liabilities | $6.0K | $0 |
| Total Current Liabilities | $11.71M | $10.42M |
| Total Non-Current Liabilities | $7.41M | $8.68M |
| Total Liabilities | $19.12M | $19.10M |
| Total Debt (incl. Leases) | $8.68M | $9.75M |
| Common Stock | $45K | $5.0K |
| Retained Earnings | -$256.4M | -$181.1M |
| Accumulated Other Comp. Income | $540K | $368K |
| Total Stockholders' Equity | $306.8M | -$163.7M |
| Total Equity | $306.8M | -$163.7M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $83.88M | $63.32M | $63.32M | $58.45M | $50.83M | $40.98M | $82.69M | $37.79M |
| Cash & Short-Term Investments | $249.8M | $268.3M | $289.9M | $58.45M | $325.0M | $337.3M | $354.7M | $37.79M |
| Total Current Assets | $228.5M | $216.1M | $221.0M | $241.4M | $252.3M | $266.7M | $273.7M | $151.0M |
| Property, Plant & Equipment, Net | $1.76M | $1.92M | $2.07M | $2.23M | $2.14M | $2.25M | $2.39M | $2.47M |
| Other Non-Current Assets | $638K | $594K | $585K | $0 | $0 | $0 | $0 | $2.99M |
| Total Non-Current Assets | $34.73M | $67.12M | $84.08M | $84.53M | $86.94M | $85.30M | $95.99M | $34.76M |
| Total Assets | $263.3M | $283.2M | $305.0M | $326.0M | $339.3M | $352.0M | $369.7M | $185.8M |
| Accounts Payable | $1.05M | $523K | $2.11M | $769K | $1.48M | $914K | $5.02M | $1.19M |
| Other Current Liabilities | $0 | $7.0K | $17K | $6.0K | $224K | -- | -- | $0 |
| Total Current Liabilities | $16.42M | $10.78M | $9.78M | $11.71M | $9.85M | $7.55M | $9.53M | $10.42M |
| Total Non-Current Liabilities | $6.32M | $6.69M | $7.05M | $7.41M | $7.75M | $8.07M | $8.38M | $8.68M |
| Total Liabilities | $22.74M | $17.47M | $16.83M | $19.12M | $17.60M | $15.62M | $17.91M | $19.10M |
| Total Debt (incl. Leases) | $7.75M | $8.07M | $8.38M | $8.68M | $8.97M | $9.24M | $9.50M | $9.75M |
| Common Stock | $45K | $45K | $45K | $45K | $44K | $44K | $44K | $5.0K |
| Retained Earnings | -$345.4M | -$313.0M | -$283.1M | -$256.4M | -$235.9M | -$215.6M | -$197.6M | -$181.1M |
| Accumulated Other Comp. Income | -$723K | -$448K | -$84K | $540K | $420K | $183K | $301K | $368K |
| Total Stockholders' Equity | $240.5M | $265.8M | $288.2M | $306.8M | $321.7M | $336.4M | $351.8M | -$163.7M |
| Total Equity | $240.5M | $265.8M | $288.2M | $306.8M | $321.7M | $336.4M | $351.8M | -$163.7M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 |
|---|---|---|
| Net Income | -$75.27M | -$61.69M |
| Depreciation & Amortization | $647K | $668K |
| Stock-Based Compensation | $12.07M | $3.71M |
| Change in Payables | -$417K | $467K |
| Operating Cash Flow | -$66.30M | -$52.79M |
| Capital Expenditure | -$377K | -$27K |
| Free Cash Flow | -$66.67M | -$52.81M |
| Purchases of Investments | -$325.0M | -$182.8M |
| Investing Cash Flow | -$118.7M | -$126.9M |
| Financing Cash Flow | $205.7M | $179.0M |
| Net Change in Cash | $20.66M | -$733K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$32.42M | -$29.89M | -$26.78M | -$20.44M | -$20.28M | -$18.07M | -$16.48M | -$15.85M |
| Depreciation & Amortization | $200K | $200K | $154K | $152K | $100K | $100K | $159K | $167K |
| Stock-Based Compensation | $7.08M | $6.84M | $6.55M | $3.83M | $3.31M | $2.84M | $2.09M | $1.06M |
| Change in Payables | $604K | -$1.53M | $1.21M | -$712K | $567K | -$3.83M | $3.55M | $1.08M |
| Operating Cash Flow | -$18.72M | -$22.22M | -$21.84M | -$16.63M | -$15.23M | -$18.15M | -$16.29M | -$11.78M |
| Capital Expenditure | $0 | $0 | $0 | -$204K | -$87K | $0 | -$86K | -$27K |
| Free Cash Flow | -$18.72M | -$22.22M | -$21.84M | -$16.83M | -$15.32M | -$18.15M | -$16.37M | -$11.81M |
| Purchases of Investments | -$11.35M | -$33.03M | -$25.33M | -$42.88M | -$54.14M | -$56.42M | -$171.6M | -$7.20M |
| Investing Cash Flow | $38.95M | $21.47M | $24.82M | $22.59M | $23.10M | -$23.25M | -$141.2M | $15.23M |
| Financing Cash Flow | $333K | $749K | $1.89M | $1.66M | $1.97M | -$312K | $202.4M | -$1.41M |
| Net Change in Cash | $20.56M | -$2.0K | $4.87M | $7.62M | $9.85M | -$41.71M | $44.91M | $2.04M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 |
|---|---|---|
| Return on Equity (ROE) | -24.5% | -- |
| Return on Assets (ROA) | -23.1% | -33.2% |
| Current Ratio | 20.61x | 14.49x |
| Quick Ratio | 4.99x | 3.63x |
| Debt to Equity | 0.03x | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -45.5% | -36.6% | -29.7% | -24.5% | -22.0% | -22.5% | -18.9% | -- |
| Return on Assets (ROA) | -41.6% | -34.4% | -28.1% | -23.1% | -20.8% | -21.5% | -17.9% | -33.2% |
| Current Ratio | 13.92x | 20.05x | 22.60x | 20.61x | 25.61x | 35.33x | 28.73x | 14.49x |
| Quick Ratio | 15.21x | 24.88x | 29.65x | 4.99x | 32.99x | 44.68x | 37.23x | 3.63x |
| Debt to Equity | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | -- |